SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
----------------------
F O R M 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of June 2005
Elscint Limited
(Name of Registrant)
13 NOAH MOZES STREET, TEL AVIV 67442, ISRAEL
(Address of Principal Executive Office)
Indicate by check mark whether the registrant files or will
file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F [X] Form 40-F [ ]
Indicate by check mark if the registrant is submitting the
Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): [ ]
Indicate by check mark if the registrant is submitting the
Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): [ ]
Indicate by check mark whether by furnishing the information
contained in this Form, the registrant is also thereby furnishing the
information to the Commission pursuant to Rule 12g3-2(b) under the Securities
Exchange Act of 1934.
Yes [ ] No [X]
If "Yes" is marked, indicate below the file number assigned to
the registrant in connection with Rule 12g3-2(b): 82-___________
Elscint Limited
Attached are the following exhibits:
99.1 Press release re Elscint Limited Announces Retention of Financial Advisor
In Connection With Negotiations On Potential Business Combination With
Elbit Medical Imaging Ltd. dated June 28, 2005.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized.
ELSCINT LIMITED
---------------
(Registrant)
By: /s/Rachel Lavine
----------------
Rachel Lavine
President
Date: June 28, 2005
EXHIBIT INDEX
-------------
EXHIBIT NO. DESCRIPTION
----------- -----------
99.1 Press release re Elscint Limited Announces Retention of
Financial Advisor In Connection With Negotiations On Potential
Business Combination With Elbit Medical Imaging Ltd. dated
June 28, 2005.